Sen. Franken Tasks GAO To Explore Incentives For Rare-Disease Devices
This article was originally published in The Gray Sheet
Executive Summary
Sen. Al Franken, D-Minn., sent a 1letter to the Government Accountability Office July 21, requesting that the watchdog agency explore government incentives to spur development of medical devices to treat rare diseases
You may also be interested in...
IOM Report Advises FDA, NIH To Spur Innovation For Rare Disease Devices
FDA and NIH should consider options for stimulating high-priority device innovations to treat rare diseases, including the creation of NIH awards, R&D tax credits and "inducement" prizes, according to an Institute of Medicine report
IOM Report Advises FDA, NIH To Spur Innovation For Rare Disease Devices
FDA and NIH should consider options for stimulating high-priority device innovations to treat rare diseases, including the creation of NIH awards, R&D tax credits and "inducement" prizes, according to an Institute of Medicine report
FDA Inches Ahead On 'ASK Children' Neuro Implant Study
The ASK Children study, an unusual, FDA-led clinical trial designed to gather data about the use of neurologic devices in children, has enrolled 18 patients since launching in March 2009